MyAverix Finance
F · Healthcare
Paradigm Biopharmaceuticals Limited (P86)
Biotechnology
Paradigm Biopharmaceuticals Limited (P86) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $68.03M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for P86
Paradigm Biopharmaceuticals Limited (P86) — FAQ
What is Paradigm Biopharmaceuticals Limited's market cap?
Paradigm Biopharmaceuticals Limited (P86) has a reported market cap of $68.03M (data as of 2026-03-30).
What is P86's P/E ratio?
The price-to-earnings (P/E) ratio for Paradigm Biopharmaceuticals Limited (P86) is 18.00 (data as of 2026-03-30).
Does Paradigm Biopharmaceuticals Limited pay a dividend?
Dividend yield is not available in the current snapshot for Paradigm Biopharmaceuticals Limited (P86). Check the MyAverix Finance app for the latest dividend data.
What sector is Paradigm Biopharmaceuticals Limited in?
Paradigm Biopharmaceuticals Limited (P86) is classified in the Healthcare sector (Biotechnology industry).
What exchange is P86 listed on?
P86 is listed on F.
What is Paradigm Biopharmaceuticals Limited's net margin?
Paradigm Biopharmaceuticals Limited (P86) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.